Réseau SEP IDF Ouest

Author Of 1 Presentation

Symptom Management Poster Presentation

P1095 - Effectiveness of a cognitive behavioral program for fatigue (FACETS +) in 110 French patients with Multiple Sclerosis : a randomized, controlled trial (ID 744)

Speakers
Presentation Number
P1095
Presentation Topic
Symptom Management

Abstract

Background

Fatigue is one of the most frequent reported symptoms in Multiple Sclerosis (MS) and is usually considered to be one of the three worst symptoms with gait and genito-sphincteral disorders. Fatigue, an invisible symptom, affects social and professional relationships and decreases quality of life.

Pharmacological and non-pharmacological therapies are available, but evidences for effectiveness are limited. To date, three RCTs using cognitive-behavioral approaches (CBT) in the context of MS have been conducted (Van Kessel, 2007; Grossman, 2010, Thomas et al., 2013). Nevertheless, the positive effect of treatment wears off over time. Thus, booster session might enhance the benefits on the long term by reinforcing the internalizations processes. FACETS, developed by Thomas and al in 2013, is promising. It is a six once-weekly sessions program focused on CBT and energy conservation, delivered in small groups, easy to implement in medical services or associations.

Objectives

1. Demonstrate the effectiveness of the FACETS program in a French context

2. To assess the effect of 4 booster sessions to the FACETS program to obtain a long-term effect (1 year).

Methods

Multicentric RCT comparing FACETS versus local practice in pwMS. Six once-weekly sessions followed by 4 booster sessions at regular intervals. The main criteria is the impact of CBT on fatigue evaluated by the Modified Fatigue Impact Scale (MFIS) at 1 year.

Results

N=105 patients recruited (F=89 VS M=16). Mean âge (years) = 46 (9,99), Mean EDSS = 2.61 (1,45). The MFIS Score mean is 54,59 (14,16), a score above 45 means that fatigue. Results at 6 weeks, 6 and 12 months will be presented during congress.

Conclusions

The programme is designed to facilitate use within health services. Thus, if the results from this trial are positive on the long term, there is potential for directly adding to the treatment options available to people with MS who have troublesome fatigue and improving the services available to them.

Collapse

Presenter Of 1 Presentation

Symptom Management Poster Presentation

P1095 - Effectiveness of a cognitive behavioral program for fatigue (FACETS +) in 110 French patients with Multiple Sclerosis : a randomized, controlled trial (ID 744)

Speakers
Presentation Number
P1095
Presentation Topic
Symptom Management

Abstract

Background

Fatigue is one of the most frequent reported symptoms in Multiple Sclerosis (MS) and is usually considered to be one of the three worst symptoms with gait and genito-sphincteral disorders. Fatigue, an invisible symptom, affects social and professional relationships and decreases quality of life.

Pharmacological and non-pharmacological therapies are available, but evidences for effectiveness are limited. To date, three RCTs using cognitive-behavioral approaches (CBT) in the context of MS have been conducted (Van Kessel, 2007; Grossman, 2010, Thomas et al., 2013). Nevertheless, the positive effect of treatment wears off over time. Thus, booster session might enhance the benefits on the long term by reinforcing the internalizations processes. FACETS, developed by Thomas and al in 2013, is promising. It is a six once-weekly sessions program focused on CBT and energy conservation, delivered in small groups, easy to implement in medical services or associations.

Objectives

1. Demonstrate the effectiveness of the FACETS program in a French context

2. To assess the effect of 4 booster sessions to the FACETS program to obtain a long-term effect (1 year).

Methods

Multicentric RCT comparing FACETS versus local practice in pwMS. Six once-weekly sessions followed by 4 booster sessions at regular intervals. The main criteria is the impact of CBT on fatigue evaluated by the Modified Fatigue Impact Scale (MFIS) at 1 year.

Results

N=105 patients recruited (F=89 VS M=16). Mean âge (years) = 46 (9,99), Mean EDSS = 2.61 (1,45). The MFIS Score mean is 54,59 (14,16), a score above 45 means that fatigue. Results at 6 weeks, 6 and 12 months will be presented during congress.

Conclusions

The programme is designed to facilitate use within health services. Thus, if the results from this trial are positive on the long term, there is potential for directly adding to the treatment options available to people with MS who have troublesome fatigue and improving the services available to them.

Collapse